Showing 1,781 - 1,800 results of 4,025 for search 'china’s globalization', query time: 0.06s Refine Results
  1. 1781
  2. 1782
  3. 1783
  4. 1784
  5. 1785
  6. 1786
  7. 1787
  8. 1788
  9. 1789
  10. 1790

    A phase I, randomized, placebo‐controlled trial to evaluate the pharmacokinetics, safety, and tolerability of nirsevimab in healthy Chinese adults by Xiaomeng Mao, Xiaohan Hua, Chengyi Wu, Xiaoyun Ge, Jie Zhang, Xiaojie Wu, Robert J. Kubiak, Ulrika Wählby Hamrén, Tonya Villafana, Georgios Christou, Jannine Green, Therese Takas, Yuwen Jin

    Published 2025-01-01
    “…Nirsevimab, an extended half‐life monoclonal antibody against RSV, is approved in China for the prevention of RSV lower respiratory tract disease in infants; however, global nirsevimab trials did not enroll Chinese infants. …”
    Get full text
    Article
  11. 1791
  12. 1792
  13. 1793
  14. 1794
  15. 1795
  16. 1796
  17. 1797
  18. 1798
  19. 1799
  20. 1800